id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-311505-akcc9oms	Geisen, Will R.	Cytomegalovirus Enterocolitis secondary to experimental COVID-19 therapy	2020-09-22		.txt	text/plain	1354	82	38	Additionally, this case validates colonoscopy as a mode to rule out concurrent infectious etiologies causing diarrhea in COVID-19-positive patients. Additionally, this case validates colonoscopy as a mode to rule out concurrent infectious etiologies causing diarrhea in COVID-19-positive patients. The novel 2019 coronavirus (COVID-19), a form of severe acute respiratory syndrome (SARS-CoV-2), has caused a pandemic of historical proportions. Due to its worldwide distribution, a paucity of clinical trial data, and a high mortality rate, the COVID pandemic has led to widespread implementation of experimental therapies with varying levels of success and, in some instances, poor outcomes (3, 4, 5) . We present a patient who was treated with experimental therapies and subsequently developed severe gastrointestinal pathology that was diagnosed by colonoscopy. The report describes a patient with SARS-CoV-2 pneumonia who was treated with experimental immunomodulating therapies and, subsequently, developed cytomegalovirus (CMV) colitis.	./cache/cord-311505-akcc9oms.txt	./txt/cord-311505-akcc9oms.txt